Selected Cell
Cell:
Value:
Pcitri.ignored_ids.dumb.final.p
Sheet3
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
15801
15802
15803
15804
15805
15806
15807
15808
15809
15810
15811
15812
15813
15814
15815
15816
15817
15818
15819
15820
15821
15822
15823
15824
15825
15826
15827
15828
15829
15830
15831
15832
15833
15834
15835
15836
15837
15838
15839
15840
15841
15842
15843
15844
15845
15846
15847
15848
15849
15850
15851
15852
15853
15854
15855
15856
15857
15858
15859
15860
15861
15862
15863
15864
15865
15866
15867
15868
15869
15870
15871
15872
15873
15874
15875
15876
15877
15878
15879
15880
15881
15882
15883
15884
15885
15886
15887
15888
15889
15890
15891
15892
15893
15894
15895
15896
15897
15898
15899
15900
15901
15902
15903
15904
15905
15906
15907
15908
15909
15910
15911
15912
15913
15914
15915
15916
15917
15918
15919
15920
15921
15922
15923
15924
15925
15926
15927
15928
15929
15930
15931
15932
15933
15934
15935
15936
15937
15938
15939
15940
15941
15942
15943
15944
15945
15946
15947
15948
15949
15950
15951
15952
15953
15954
15955
15956
15957
15958
15959
15960
15961
15962
15963
15964
15965
15966
15967
15968
15969
15970
15971
15972
15973
15974
15975
15976
15977
15978
15979
15980
15981
15982
15983
15984
15985
15986
15987
15988
15989
15990
15991
15992
15993
15994
15995
15996
15997
15998
15999
16000
| UnnamedSample_HQ_transcript/111248|m.23990 | UnnamedSample_HQ_transcript/111248 | Coverage 0.733 too low. | b3dce56dfa051059e8934ddc2a771b89 | 218 | Pfam | PF01395 | PBP/GOBP family | 25 | 140 | 2.4E-6 | T | 22-09-2020 | IPR006170 | Pheromone/general odorant binding protein |
| UnnamedSample_HQ_transcript/5493|m.2360 | UnnamedSample_HQ_transcript/5493 | Coverage 0.559 too low. | aa9803c816a9d0e12e72a109814a6ed6 | 1242 | Pfam | PF00788 | Ras association (RalGDS/AF-6) domain | 500 | 576 | 6.5E-5 | T | 22-09-2020 | IPR000159 | Ras-associating (RA) domain |
| UnnamedSample_HQ_transcript/5493|m.2360 | UnnamedSample_HQ_transcript/5493 | Coverage 0.559 too low. | aa9803c816a9d0e12e72a109814a6ed6 | 1242 | Pfam | PF00620 | RhoGAP domain | 659 | 803 | 3.7E-32 | T | 22-09-2020 | IPR000198 | Rho GTPase-activating protein domain |
| UnnamedSample_HQ_transcript/5493|m.2360 | UnnamedSample_HQ_transcript/5493 | Coverage 0.559 too low. | aa9803c816a9d0e12e72a109814a6ed6 | 1242 | Pfam | PF00621 | RhoGEF domain | 144 | 312 | 5.8E-11 | T | 22-09-2020 | IPR000219 | Dbl homology (DH) domain |
| UnnamedSample_HQ_transcript/3371|m.1583 | UnnamedSample_HQ_transcript/3371 | Coverage 0.497 too low. | aa9803c816a9d0e12e72a109814a6ed6 | 1242 | Pfam | PF00788 | Ras association (RalGDS/AF-6) domain | 500 | 576 | 6.5E-5 | T | 22-09-2020 | IPR000159 | Ras-associating (RA) domain |
| UnnamedSample_HQ_transcript/3371|m.1583 | UnnamedSample_HQ_transcript/3371 | Coverage 0.497 too low. | aa9803c816a9d0e12e72a109814a6ed6 | 1242 | Pfam | PF00620 | RhoGAP domain | 659 | 803 | 3.7E-32 | T | 22-09-2020 | IPR000198 | Rho GTPase-activating protein domain |
| UnnamedSample_HQ_transcript/3371|m.1583 | UnnamedSample_HQ_transcript/3371 | Coverage 0.497 too low. | aa9803c816a9d0e12e72a109814a6ed6 | 1242 | Pfam | PF00621 | RhoGEF domain | 144 | 312 | 5.8E-11 | T | 22-09-2020 | IPR000219 | Dbl homology (DH) domain |
| UnnamedSample_HQ_transcript/39463|m.11736 | UnnamedSample_HQ_transcript/39463 | Identity 0.792 too low. | 43e885eaa99daf270f45f0e736c9a2bd | 421 | Pfam | PF01733 | Nucleoside transporter | 228 | 412 | 2.7E-40 | T | 22-09-2020 | IPR002259 | Equilibrative nucleoside transporter |
| UnnamedSample_HQ_transcript/45555|m.13050 | UnnamedSample_HQ_transcript/45555 | Identity 0.860 too low. | 43e885eaa99daf270f45f0e736c9a2bd | 421 | Pfam | PF01733 | Nucleoside transporter | 228 | 412 | 2.7E-40 | T | 22-09-2020 | IPR002259 | Equilibrative nucleoside transporter |
| UnnamedSample_HQ_transcript/51223|m.14285 | UnnamedSample_HQ_transcript/51223 | Coverage 0.986 too low. | 43e885eaa99daf270f45f0e736c9a2bd | 421 | Pfam | PF01733 | Nucleoside transporter | 228 | 412 | 2.7E-40 | T | 22-09-2020 | IPR002259 | Equilibrative nucleoside transporter |
| UnnamedSample_HQ_transcript/23633|m.7845 | UnnamedSample_HQ_transcript/23633 | Coverage 0.902 too low. | 1b32600ef6536053cc9c4fff071c485a | 743 | Pfam | PF14598 | PAS domain | 132 | 241 | 4.5E-32 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/55474|m.15128 | UnnamedSample_HQ_transcript/55474 | Coverage 0.384 too low. | c721ba43e499da201ea5c0b762b7ceca | 473 | Pfam | PF00083 | Sugar (and other) transporter | 52 | 452 | 7.3E-71 | T | 22-09-2020 | IPR005828 | Major facilitator, sugar transporter-like |
| UnnamedSample_HQ_transcript/42501|m.12374 | UnnamedSample_HQ_transcript/42501 | Coverage 0.220 too low. | c721ba43e499da201ea5c0b762b7ceca | 473 | Pfam | PF00083 | Sugar (and other) transporter | 52 | 452 | 7.3E-71 | T | 22-09-2020 | IPR005828 | Major facilitator, sugar transporter-like |
| UnnamedSample_HQ_transcript/68686|m.17704 | UnnamedSample_HQ_transcript/68686 | Coverage 0.296 too low. | c721ba43e499da201ea5c0b762b7ceca | 473 | Pfam | PF00083 | Sugar (and other) transporter | 52 | 452 | 7.3E-71 | T | 22-09-2020 | IPR005828 | Major facilitator, sugar transporter-like |
| UnnamedSample_HQ_transcript/67376|m.17469 | UnnamedSample_HQ_transcript/67376 | Coverage 0.439 too low. | c721ba43e499da201ea5c0b762b7ceca | 473 | Pfam | PF00083 | Sugar (and other) transporter | 52 | 452 | 7.3E-71 | T | 22-09-2020 | IPR005828 | Major facilitator, sugar transporter-like |
| UnnamedSample_HQ_transcript/81356|m.19939 | UnnamedSample_HQ_transcript/81356 | Coverage 0.346 too low. | c721ba43e499da201ea5c0b762b7ceca | 473 | Pfam | PF00083 | Sugar (and other) transporter | 52 | 452 | 7.3E-71 | T | 22-09-2020 | IPR005828 | Major facilitator, sugar transporter-like |
| UnnamedSample_HQ_transcript/42722|m.12423 | UnnamedSample_HQ_transcript/42722 | Coverage 0.345 too low. | 66349d357b68c804c0843da91216e864 | 706 | Pfam | PF00211 | Adenylate and Guanylate cyclase catalytic domain | 488 | 658 | 1.2E-61 | T | 22-09-2020 | IPR001054 | Adenylyl cyclase class-3/4/guanylyl cyclase |
| UnnamedSample_HQ_transcript/42722|m.12423 | UnnamedSample_HQ_transcript/42722 | Coverage 0.345 too low. | 66349d357b68c804c0843da91216e864 | 706 | Pfam | PF07701 | Heme NO binding associated | 377 | 481 | 1.6E-28 | T | 22-09-2020 | IPR011645 | Haem NO binding associated |
| UnnamedSample_HQ_transcript/42722|m.12423 | UnnamedSample_HQ_transcript/42722 | Coverage 0.345 too low. | 66349d357b68c804c0843da91216e864 | 706 | Pfam | PF07701 | Heme NO binding associated | 291 | 370 | 6.1E-14 | T | 22-09-2020 | IPR011645 | Haem NO binding associated |
| UnnamedSample_HQ_transcript/84089|m.20353 | UnnamedSample_HQ_transcript/84089 | Identity 0.720 too low. | 8825e547e8e10e6b520c74bab80a921e | 377 | Pfam | PF12738 | twin BRCT domain | 115 | 177 | 1.4E-17 | T | 22-09-2020 | IPR001357 | BRCT domain |
| UnnamedSample_HQ_transcript/84089|m.20353 | UnnamedSample_HQ_transcript/84089 | Identity 0.720 too low. | 8825e547e8e10e6b520c74bab80a921e | 377 | Pfam | PF00533 | BRCA1 C Terminus (BRCT) domain | 204 | 275 | 2.9E-6 | T | 22-09-2020 | IPR001357 | BRCT domain |
| UnnamedSample_HQ_transcript/73672|m.18595 | UnnamedSample_HQ_transcript/73672 | Coverage 0.880 too low. | b768a0d02722adafa94bdb2cda49ef2a | 332 | Pfam | PF01490 | Transmembrane amino acid transporter protein | 4 | 304 | 1.7E-50 | T | 22-09-2020 | IPR013057 | Amino acid transporter, transmembrane domain |
| UnnamedSample_HQ_transcript/49364|m.13878 | UnnamedSample_HQ_transcript/49364 | Coverage 0.588 too low. | 2b34513e5f1b86c595667a0f8e9cf8f0 | 422 | Pfam | PF00096 | Zinc finger, C2H2 type | 395 | 418 | 4.2E-5 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/49364|m.13878 | UnnamedSample_HQ_transcript/49364 | Coverage 0.588 too low. | 2b34513e5f1b86c595667a0f8e9cf8f0 | 422 | Pfam | PF00651 | BTB/POZ domain | 23 | 116 | 1.4E-24 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/94258|m.21842 | UnnamedSample_HQ_transcript/94258 | Coverage 0.214 too low. | dc3cfba2d4315f46d36c028d2910ca99 | 300 | Pfam | PF07690 | Major Facilitator Superfamily | 49 | 213 | 8.2E-10 | T | 22-09-2020 | IPR011701 | Major facilitator superfamily |
| UnnamedSample_HQ_transcript/116455|m.24533 | UnnamedSample_HQ_transcript/116455 | Coverage 0.858 too low. | 058bd5d0fba75ee569ffcc078ba2ac20 | 223 | Pfam | PF00400 | WD domain, G-beta repeat | 38 | 74 | 4.5E-10 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/116455|m.24533 | UnnamedSample_HQ_transcript/116455 | Coverage 0.858 too low. | 058bd5d0fba75ee569ffcc078ba2ac20 | 223 | Pfam | PF00400 | WD domain, G-beta repeat | 80 | 137 | 1.9E-5 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/116455|m.24533 | UnnamedSample_HQ_transcript/116455 | Coverage 0.858 too low. | 058bd5d0fba75ee569ffcc078ba2ac20 | 223 | Pfam | PF00400 | WD domain, G-beta repeat | 184 | 220 | 2.0E-7 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/116455|m.24533 | UnnamedSample_HQ_transcript/116455 | Coverage 0.858 too low. | 058bd5d0fba75ee569ffcc078ba2ac20 | 223 | Pfam | PF00400 | WD domain, G-beta repeat | 2 | 32 | 1.1E-7 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/116455|m.24533 | UnnamedSample_HQ_transcript/116455 | Coverage 0.858 too low. | 058bd5d0fba75ee569ffcc078ba2ac20 | 223 | Pfam | PF00400 | WD domain, G-beta repeat | 141 | 179 | 1.5E-10 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/105695|m.23307 | UnnamedSample_HQ_transcript/105695 | Coverage 0.639 too low. | 058bd5d0fba75ee569ffcc078ba2ac20 | 223 | Pfam | PF00400 | WD domain, G-beta repeat | 38 | 74 | 4.5E-10 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/105695|m.23307 | UnnamedSample_HQ_transcript/105695 | Coverage 0.639 too low. | 058bd5d0fba75ee569ffcc078ba2ac20 | 223 | Pfam | PF00400 | WD domain, G-beta repeat | 80 | 137 | 1.9E-5 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/105695|m.23307 | UnnamedSample_HQ_transcript/105695 | Coverage 0.639 too low. | 058bd5d0fba75ee569ffcc078ba2ac20 | 223 | Pfam | PF00400 | WD domain, G-beta repeat | 184 | 220 | 2.0E-7 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/105695|m.23307 | UnnamedSample_HQ_transcript/105695 | Coverage 0.639 too low. | 058bd5d0fba75ee569ffcc078ba2ac20 | 223 | Pfam | PF00400 | WD domain, G-beta repeat | 2 | 32 | 1.1E-7 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/105695|m.23307 | UnnamedSample_HQ_transcript/105695 | Coverage 0.639 too low. | 058bd5d0fba75ee569ffcc078ba2ac20 | 223 | Pfam | PF00400 | WD domain, G-beta repeat | 141 | 179 | 1.5E-10 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/65271|m.17075 | UnnamedSample_HQ_transcript/65271 | Coverage 0.059 too low. | 5f7e79395310ee20a975e1e027c77e50 | 532 | Pfam | PF00646 | F-box domain | 80 | 123 | 4.0E-8 | T | 22-09-2020 | IPR001810 | F-box domain |
| UnnamedSample_HQ_transcript/19760|m.6804 | UnnamedSample_HQ_transcript/19760 | Coverage 0.986 too low. | 1efa5b880975a33400ff448edcd40817 | 300 | Pfam | PF00096 | Zinc finger, C2H2 type | 165 | 187 | 9.5E-4 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/19760|m.6804 | UnnamedSample_HQ_transcript/19760 | Coverage 0.986 too low. | 1efa5b880975a33400ff448edcd40817 | 300 | Pfam | PF00096 | Zinc finger, C2H2 type | 137 | 159 | 8.1E-5 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/19760|m.6804 | UnnamedSample_HQ_transcript/19760 | Coverage 0.986 too low. | 1efa5b880975a33400ff448edcd40817 | 300 | Pfam | PF00096 | Zinc finger, C2H2 type | 107 | 131 | 1.5E-6 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/9112|m.3546 | UnnamedSample_HQ_transcript/9112 | Identity 0.950 too low. | a333f95cad2142f9fa19768d6b941cd8 | 602 | Pfam | PF13246 | Cation transport ATPase (P-type) | 1 | 109 | 3.0E-18 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/9112|m.3546 | UnnamedSample_HQ_transcript/9112 | Identity 0.950 too low. | a333f95cad2142f9fa19768d6b941cd8 | 602 | Pfam | PF00689 | Cation transporting ATPase, C-terminus | 366 | 569 | 1.1E-42 | T | 22-09-2020 | IPR006068 | Cation-transporting P-type ATPase, C-terminal |
| UnnamedSample_HQ_transcript/9112|m.3546 | UnnamedSample_HQ_transcript/9112 | Identity 0.950 too low. | a333f95cad2142f9fa19768d6b941cd8 | 602 | Pfam | PF00702 | haloacid dehalogenase-like hydrolase | 174 | 296 | 4.9E-15 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/107560|m.23530 | UnnamedSample_HQ_transcript/107560 | Coverage 0.324 too low. | 8d13d442e581485d17e9f81514436bce | 242 | Pfam | PF00010 | Helix-loop-helix DNA-binding domain | 29 | 75 | 1.9E-8 | T | 22-09-2020 | IPR011598 | Myc-type, basic helix-loop-helix (bHLH) domain |
| UnnamedSample_HQ_transcript/107560|m.23530 | UnnamedSample_HQ_transcript/107560 | Coverage 0.324 too low. | 8d13d442e581485d17e9f81514436bce | 242 | Pfam | PF00989 | PAS fold | 107 | 160 | 1.3E-5 | T | 22-09-2020 | IPR013767 | PAS fold |
| UnnamedSample_HQ_transcript/65874|m.17182 | UnnamedSample_HQ_transcript/65874 | Coverage 0.977 too low. | 9101f7a22f9bb33f82ddecd1b5233288 | 552 | Pfam | PF09763 | Exocyst complex component Sec3 | 196 | 530 | 3.8E-67 | T | 22-09-2020 | IPR019160 | Exocyst complex component Sec3, C-terminal |
| UnnamedSample_HQ_transcript/65874|m.17182 | UnnamedSample_HQ_transcript/65874 | Coverage 0.977 too low. | 9101f7a22f9bb33f82ddecd1b5233288 | 552 | Pfam | PF15277 | Exocyst complex component SEC3 N-terminal PIP2 binding PH | 33 | 121 | 2.4E-22 | T | 22-09-2020 | IPR028258 | Exocyst complex component Sec3, PIP2-binding N-terminal domain |
| UnnamedSample_HQ_transcript/40105|m.11866 | UnnamedSample_HQ_transcript/40105 | Coverage 0.727 too low. | 1ac5017f91f0686ab9ada1ba470972eb | 491 | Pfam | PF00083 | Sugar (and other) transporter | 33 | 466 | 3.4E-95 | T | 22-09-2020 | IPR005828 | Major facilitator, sugar transporter-like |
| UnnamedSample_HQ_transcript/46676|m.13291 | UnnamedSample_HQ_transcript/46676 | Coverage 0.173 too low. | 7b3a35cbd6db415090c39e99c9ab6a98 | 278 | Pfam | PF02826 | D-isomer specific 2-hydroxyacid dehydrogenase, NAD binding domain | 134 | 260 | 3.5E-29 | T | 22-09-2020 | IPR006140 | D-isomer specific 2-hydroxyacid dehydrogenase, NAD-binding domain |
| UnnamedSample_HQ_transcript/46676|m.13291 | UnnamedSample_HQ_transcript/46676 | Coverage 0.173 too low. | 7b3a35cbd6db415090c39e99c9ab6a98 | 278 | Pfam | PF00389 | D-isomer specific 2-hydroxyacid dehydrogenase, catalytic domain | 39 | 133 | 1.0E-25 | T | 22-09-2020 | IPR006139 | D-isomer specific 2-hydroxyacid dehydrogenase, catalytic domain |
| UnnamedSample_HQ_transcript/2948|m.1426 | UnnamedSample_HQ_transcript/2948 | Coverage 0.843 too low. | 5ac9e952e480e9b23dcf2f700ed9c09a | 812 | Pfam | PF13639 | Ring finger domain | 733 | 776 | 1.0E-14 | T | 22-09-2020 | IPR001841 | Zinc finger, RING-type |
| UnnamedSample_HQ_transcript/483|m.358 | UnnamedSample_HQ_transcript/483 | Identity 0.849 too low. | 5ac9e952e480e9b23dcf2f700ed9c09a | 812 | Pfam | PF13639 | Ring finger domain | 733 | 776 | 1.0E-14 | T | 22-09-2020 | IPR001841 | Zinc finger, RING-type |
| UnnamedSample_HQ_transcript/20783|m.7088 | UnnamedSample_HQ_transcript/20783 | Unmapped. | b4214a934834a8bd6ae2adbcd8576618 | 750 | Pfam | PF00014 | Kunitz/Bovine pancreatic trypsin inhibitor domain | 289 | 340 | 3.4E-19 | T | 22-09-2020 | IPR002223 | Pancreatic trypsin inhibitor Kunitz domain |
| UnnamedSample_HQ_transcript/20783|m.7088 | UnnamedSample_HQ_transcript/20783 | Unmapped. | b4214a934834a8bd6ae2adbcd8576618 | 750 | Pfam | PF02177 | Amyloid A4 N-terminal heparin-binding | 31 | 131 | 8.5E-45 | T | 22-09-2020 | IPR015849 | Amyloidogenic glycoprotein, heparin-binding |
| UnnamedSample_HQ_transcript/20783|m.7088 | UnnamedSample_HQ_transcript/20783 | Unmapped. | b4214a934834a8bd6ae2adbcd8576618 | 750 | Pfam | PF10515 | Beta-amyloid precursor protein C-terminus | 696 | 746 | 8.0E-25 | T | 22-09-2020 | IPR019543 | Beta-amyloid precursor protein C-terminal |
| UnnamedSample_HQ_transcript/20783|m.7088 | UnnamedSample_HQ_transcript/20783 | Unmapped. | b4214a934834a8bd6ae2adbcd8576618 | 750 | Pfam | PF03494 | Beta-amyloid peptide (beta-APP) | 656 | 693 | 1.8E-22 | T | 22-09-2020 | IPR013803 | Amyloidogenic glycoprotein, amyloid-beta peptide |
| UnnamedSample_HQ_transcript/20783|m.7088 | UnnamedSample_HQ_transcript/20783 | Unmapped. | b4214a934834a8bd6ae2adbcd8576618 | 750 | Pfam | PF12925 | E2 domain of amyloid precursor protein | 346 | 528 | 6.6E-71 | T | 22-09-2020 | IPR024329 | Amyloidogenic glycoprotein, E2 domain |
| UnnamedSample_HQ_transcript/20783|m.7088 | UnnamedSample_HQ_transcript/20783 | Unmapped. | b4214a934834a8bd6ae2adbcd8576618 | 750 | Pfam | PF12924 | Copper-binding of amyloid precursor, CuBD | 132 | 188 | 6.1E-27 | T | 22-09-2020 | IPR011178 | Amyloidogenic glycoprotein, copper-binding |
| UnnamedSample_HQ_transcript/50802|m.14203 | UnnamedSample_HQ_transcript/50802 | Coverage 0.878 too low. | 5266db825cb170955c760757a3166d84 | 663 | Pfam | PF03137 | Organic Anion Transporter Polypeptide (OATP) family | 53 | 613 | 3.2E-145 | T | 22-09-2020 | IPR004156 | Organic anion transporter polypeptide |
| UnnamedSample_HQ_transcript/93408|m.21723 | UnnamedSample_HQ_transcript/93408 | Coverage 0.835 too low. | 7ce46fbfc19851a11c5ca96f3f7fc9a0 | 168 | Pfam | PF00615 | Regulator of G protein signaling domain | 55 | 167 | 3.6E-18 | T | 22-09-2020 | IPR016137 | RGS domain |
| UnnamedSample_HQ_transcript/39087|m.11653 | UnnamedSample_HQ_transcript/39087 | Coverage 0.033 too low. | 74321606a9c9029b36f94c4381b43196 | 483 | Pfam | PF03446 | NAD binding domain of 6-phosphogluconate dehydrogenase | 6 | 166 | 2.5E-49 | T | 22-09-2020 | IPR006115 | 6-phosphogluconate dehydrogenase, NADP-binding |
| UnnamedSample_HQ_transcript/39087|m.11653 | UnnamedSample_HQ_transcript/39087 | Coverage 0.033 too low. | 74321606a9c9029b36f94c4381b43196 | 483 | Pfam | PF00393 | 6-phosphogluconate dehydrogenase, C-terminal domain | 180 | 469 | 8.5E-131 | T | 22-09-2020 | IPR006114 | 6-phosphogluconate dehydrogenase, C-terminal |
| UnnamedSample_HQ_transcript/12309|m.4594 | UnnamedSample_HQ_transcript/12309 | Coverage 0.030 too low. | b022443a97ff0531b92983d78fcb315a | 650 | Pfam | PF00083 | Sugar (and other) transporter | 189 | 621 | 9.6E-91 | T | 22-09-2020 | IPR005828 | Major facilitator, sugar transporter-like |
| UnnamedSample_HQ_transcript/54744|m.14993 | UnnamedSample_HQ_transcript/54744 | Coverage 0.057 too low. | b022443a97ff0531b92983d78fcb315a | 650 | Pfam | PF00083 | Sugar (and other) transporter | 189 | 621 | 9.6E-91 | T | 22-09-2020 | IPR005828 | Major facilitator, sugar transporter-like |
| UnnamedSample_HQ_transcript/9162|m.3564 | UnnamedSample_HQ_transcript/9162 | Coverage 0.029 too low. | b022443a97ff0531b92983d78fcb315a | 650 | Pfam | PF00083 | Sugar (and other) transporter | 189 | 621 | 9.6E-91 | T | 22-09-2020 | IPR005828 | Major facilitator, sugar transporter-like |
| UnnamedSample_HQ_transcript/33002|m.10211 | UnnamedSample_HQ_transcript/33002 | Coverage 0.275 too low. | b022443a97ff0531b92983d78fcb315a | 650 | Pfam | PF00083 | Sugar (and other) transporter | 189 | 621 | 9.6E-91 | T | 22-09-2020 | IPR005828 | Major facilitator, sugar transporter-like |
| UnnamedSample_HQ_transcript/20151|m.6910 | UnnamedSample_HQ_transcript/20151 | Coverage 0.410 too low. | b022443a97ff0531b92983d78fcb315a | 650 | Pfam | PF00083 | Sugar (and other) transporter | 189 | 621 | 9.6E-91 | T | 22-09-2020 | IPR005828 | Major facilitator, sugar transporter-like |
| UnnamedSample_HQ_transcript/34918|m.10701 | UnnamedSample_HQ_transcript/34918 | Coverage 0.064 too low. | b022443a97ff0531b92983d78fcb315a | 650 | Pfam | PF00083 | Sugar (and other) transporter | 189 | 621 | 9.6E-91 | T | 22-09-2020 | IPR005828 | Major facilitator, sugar transporter-like |
| UnnamedSample_HQ_transcript/35497|m.10814 | UnnamedSample_HQ_transcript/35497 | Coverage 0.087 too low. | fd31a574c1ec9a1026fb2da5e7dcb710 | 333 | Pfam | PF17725 | YAP binding domain | 121 | 330 | 3.1E-86 | T | 22-09-2020 | IPR041086 | YAP binding domain |
| UnnamedSample_HQ_transcript/94887|m.21942 | UnnamedSample_HQ_transcript/94887 | Coverage 0.964 too low. | fd31a574c1ec9a1026fb2da5e7dcb710 | 333 | Pfam | PF17725 | YAP binding domain | 121 | 330 | 3.1E-86 | T | 22-09-2020 | IPR041086 | YAP binding domain |
| UnnamedSample_HQ_transcript/57096|m.15468 | UnnamedSample_HQ_transcript/57096 | Coverage 0.968 too low. | 2e16b636b5f0c62a50b9e02eec28d59c | 435 | Pfam | PF02958 | Ecdysteroid kinase | 51 | 336 | 7.1E-56 | T | 22-09-2020 | IPR004119 | Ecdysteroid kinase-like |
| UnnamedSample_HQ_transcript/48279|m.13644 | UnnamedSample_HQ_transcript/48279 | Coverage 0.829 too low. | a95e64b5028aefbb28e7db8ff00c52e8 | 457 | Pfam | PF00001 | 7 transmembrane receptor (rhodopsin family) | 75 | 394 | 1.5E-79 | T | 22-09-2020 | IPR017452 | GPCR, rhodopsin-like, 7TM |
| UnnamedSample_HQ_transcript/3010|m.1446 | UnnamedSample_HQ_transcript/3010 | Coverage 0.840 too low. | df61e7eabf6320cf8b947581600b60bb | 415 | Pfam | PF00567 | Tudor domain | 70 | 137 | 1.9E-7 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/3010|m.1446 | UnnamedSample_HQ_transcript/3010 | Coverage 0.840 too low. | df61e7eabf6320cf8b947581600b60bb | 415 | Pfam | PF00567 | Tudor domain | 240 | 346 | 8.0E-20 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/21648|m.7326 | UnnamedSample_HQ_transcript/21648 | Identity 0.909 too low. | ef42ad39bddf62a3b8fd3296747782d5 | 523 | Pfam | PF03165 | MH1 domain | 53 | 153 | 1.7E-39 | T | 22-09-2020 | IPR003619 | MAD homology 1, Dwarfin-type |
| UnnamedSample_HQ_transcript/21648|m.7326 | UnnamedSample_HQ_transcript/21648 | Identity 0.909 too low. | ef42ad39bddf62a3b8fd3296747782d5 | 523 | Pfam | PF03166 | MH2 domain | 295 | 502 | 2.3E-70 | T | 22-09-2020 | IPR001132 | SMAD domain, Dwarfin-type |
| UnnamedSample_HQ_transcript/58332|m.15717 | UnnamedSample_HQ_transcript/58332 | Identity 0.925 too low. | ef42ad39bddf62a3b8fd3296747782d5 | 523 | Pfam | PF03165 | MH1 domain | 53 | 153 | 1.7E-39 | T | 22-09-2020 | IPR003619 | MAD homology 1, Dwarfin-type |
| UnnamedSample_HQ_transcript/58332|m.15717 | UnnamedSample_HQ_transcript/58332 | Identity 0.925 too low. | ef42ad39bddf62a3b8fd3296747782d5 | 523 | Pfam | PF03166 | MH2 domain | 295 | 502 | 2.3E-70 | T | 22-09-2020 | IPR001132 | SMAD domain, Dwarfin-type |
| UnnamedSample_HQ_transcript/30597|m.9613 | UnnamedSample_HQ_transcript/30597 | Identity 0.897 too low. | ef42ad39bddf62a3b8fd3296747782d5 | 523 | Pfam | PF03165 | MH1 domain | 53 | 153 | 1.7E-39 | T | 22-09-2020 | IPR003619 | MAD homology 1, Dwarfin-type |
| UnnamedSample_HQ_transcript/30597|m.9613 | UnnamedSample_HQ_transcript/30597 | Identity 0.897 too low. | ef42ad39bddf62a3b8fd3296747782d5 | 523 | Pfam | PF03166 | MH2 domain | 295 | 502 | 2.3E-70 | T | 22-09-2020 | IPR001132 | SMAD domain, Dwarfin-type |
| UnnamedSample_HQ_transcript/22133|m.7468 | UnnamedSample_HQ_transcript/22133 | Coverage 0.966 too low. | ef42ad39bddf62a3b8fd3296747782d5 | 523 | Pfam | PF03165 | MH1 domain | 53 | 153 | 1.7E-39 | T | 22-09-2020 | IPR003619 | MAD homology 1, Dwarfin-type |
| UnnamedSample_HQ_transcript/22133|m.7468 | UnnamedSample_HQ_transcript/22133 | Coverage 0.966 too low. | ef42ad39bddf62a3b8fd3296747782d5 | 523 | Pfam | PF03166 | MH2 domain | 295 | 502 | 2.3E-70 | T | 22-09-2020 | IPR001132 | SMAD domain, Dwarfin-type |
| UnnamedSample_HQ_transcript/65249|m.17069 | UnnamedSample_HQ_transcript/65249 | Identity 0.889 too low. | ef42ad39bddf62a3b8fd3296747782d5 | 523 | Pfam | PF03165 | MH1 domain | 53 | 153 | 1.7E-39 | T | 22-09-2020 | IPR003619 | MAD homology 1, Dwarfin-type |
| UnnamedSample_HQ_transcript/65249|m.17069 | UnnamedSample_HQ_transcript/65249 | Identity 0.889 too low. | ef42ad39bddf62a3b8fd3296747782d5 | 523 | Pfam | PF03166 | MH2 domain | 295 | 502 | 2.3E-70 | T | 22-09-2020 | IPR001132 | SMAD domain, Dwarfin-type |
| UnnamedSample_HQ_transcript/66806|m.17367 | UnnamedSample_HQ_transcript/66806 | Coverage 0.137 too low. | 052a14d2167b579e3ef64de5d9cd7bca | 528 | Pfam | PF00501 | AMP-binding enzyme | 30 | 432 | 6.0E-87 | T | 22-09-2020 | IPR000873 | AMP-dependent synthetase/ligase |
| UnnamedSample_HQ_transcript/66806|m.17367 | UnnamedSample_HQ_transcript/66806 | Coverage 0.137 too low. | 052a14d2167b579e3ef64de5d9cd7bca | 528 | Pfam | PF13193 | AMP-binding enzyme C-terminal domain | 441 | 517 | 3.5E-18 | T | 22-09-2020 | IPR025110 | AMP-binding enzyme, C-terminal domain |
| UnnamedSample_HQ_transcript/22107|m.7459 | UnnamedSample_HQ_transcript/22107 | Identity 0.711 too low. | 1997acae01afe2e8b03124a147a14c6d | 313 | Pfam | PF00595 | PDZ domain | 110 | 186 | 3.0E-12 | T | 22-09-2020 | IPR001478 | PDZ domain |
| UnnamedSample_HQ_transcript/67585|m.17506 | UnnamedSample_HQ_transcript/67585 | Coverage 0.390 too low. | 94ac24247de992d85b171c15e1915679 | 448 | Pfam | PF00501 | AMP-binding enzyme | 31 | 317 | 6.4E-42 | T | 22-09-2020 | IPR000873 | AMP-dependent synthetase/ligase |
| UnnamedSample_HQ_transcript/99681|m.22586 | UnnamedSample_HQ_transcript/99681 | Identity 0.883 too low. | b816d192528d6324ab1f4326dad7986d | 204 | Pfam | PF13869 | Nucleotide hydrolase | 14 | 199 | 1.2E-78 | T | 22-09-2020 | IPR016706 | Cleavage/polyadenylation specificity factor subunit 5 |
| UnnamedSample_HQ_transcript/36703|m.11095 | UnnamedSample_HQ_transcript/36703 | Coverage 0.241 too low. | 184c496d6c74a4d4c1a46d655d6566f9 | 452 | Pfam | PF00240 | Ubiquitin family | 30 | 96 | 8.5E-7 | T | 22-09-2020 | IPR000626 | Ubiquitin-like domain |
| UnnamedSample_HQ_transcript/44253|m.12767 | UnnamedSample_HQ_transcript/44253 | Coverage 0.747 too low. | 0a27b1a527126ba52d954ded7f17fc9a | 340 | Pfam | PF00083 | Sugar (and other) transporter | 12 | 308 | 2.6E-49 | T | 22-09-2020 | IPR005828 | Major facilitator, sugar transporter-like |
| UnnamedSample_HQ_transcript/39335|m.11718 | UnnamedSample_HQ_transcript/39335 | Coverage 0.703 too low. | 0a27b1a527126ba52d954ded7f17fc9a | 340 | Pfam | PF00083 | Sugar (and other) transporter | 12 | 308 | 2.6E-49 | T | 22-09-2020 | IPR005828 | Major facilitator, sugar transporter-like |
| UnnamedSample_HQ_transcript/55024|m.15044 | UnnamedSample_HQ_transcript/55024 | Coverage 0.744 too low. | 2d978c18b3ca441ef1369b3cf3e8333b | 283 | Pfam | PF07809 | RTP801 C-terminal region | 163 | 278 | 3.3E-44 | T | 22-09-2020 | IPR012918 | RTP801-like |
| UnnamedSample_HQ_transcript/97653|m.22322 | UnnamedSample_HQ_transcript/97653 | Coverage 0.610 too low. | 2d978c18b3ca441ef1369b3cf3e8333b | 283 | Pfam | PF07809 | RTP801 C-terminal region | 163 | 278 | 3.3E-44 | T | 22-09-2020 | IPR012918 | RTP801-like |
| UnnamedSample_HQ_transcript/19525|m.6729 | UnnamedSample_HQ_transcript/19525 | Coverage 0.874 too low. | 2d978c18b3ca441ef1369b3cf3e8333b | 283 | Pfam | PF07809 | RTP801 C-terminal region | 163 | 278 | 3.3E-44 | T | 22-09-2020 | IPR012918 | RTP801-like |
| UnnamedSample_HQ_transcript/17159|m.6057 | UnnamedSample_HQ_transcript/17159 | Coverage 0.845 too low. | 2d978c18b3ca441ef1369b3cf3e8333b | 283 | Pfam | PF07809 | RTP801 C-terminal region | 163 | 278 | 3.3E-44 | T | 22-09-2020 | IPR012918 | RTP801-like |
| UnnamedSample_HQ_transcript/90415|m.21316 | UnnamedSample_HQ_transcript/90415 | Coverage 0.661 too low. | 2d978c18b3ca441ef1369b3cf3e8333b | 283 | Pfam | PF07809 | RTP801 C-terminal region | 163 | 278 | 3.3E-44 | T | 22-09-2020 | IPR012918 | RTP801-like |
| UnnamedSample_HQ_transcript/92712|m.21623 | UnnamedSample_HQ_transcript/92712 | Coverage 0.562 too low. | 2d978c18b3ca441ef1369b3cf3e8333b | 283 | Pfam | PF07809 | RTP801 C-terminal region | 163 | 278 | 3.3E-44 | T | 22-09-2020 | IPR012918 | RTP801-like |
| UnnamedSample_HQ_transcript/63250|m.16681 | UnnamedSample_HQ_transcript/63250 | Coverage 0.713 too low. | 2d978c18b3ca441ef1369b3cf3e8333b | 283 | Pfam | PF07809 | RTP801 C-terminal region | 163 | 278 | 3.3E-44 | T | 22-09-2020 | IPR012918 | RTP801-like |
| UnnamedSample_HQ_transcript/90024|m.21259 | UnnamedSample_HQ_transcript/90024 | Coverage 0.604 too low. | 2d978c18b3ca441ef1369b3cf3e8333b | 283 | Pfam | PF07809 | RTP801 C-terminal region | 163 | 278 | 3.3E-44 | T | 22-09-2020 | IPR012918 | RTP801-like |
| UnnamedSample_HQ_transcript/19454|m.6716 | UnnamedSample_HQ_transcript/19454 | Coverage 0.837 too low. | 2d978c18b3ca441ef1369b3cf3e8333b | 283 | Pfam | PF07809 | RTP801 C-terminal region | 163 | 278 | 3.3E-44 | T | 22-09-2020 | IPR012918 | RTP801-like |
| UnnamedSample_HQ_transcript/47743|m.13519 | UnnamedSample_HQ_transcript/47743 | Coverage 0.679 too low. | 2d978c18b3ca441ef1369b3cf3e8333b | 283 | Pfam | PF07809 | RTP801 C-terminal region | 163 | 278 | 3.3E-44 | T | 22-09-2020 | IPR012918 | RTP801-like |
| UnnamedSample_HQ_transcript/58611|m.15777 | UnnamedSample_HQ_transcript/58611 | Coverage 0.771 too low. | 2d978c18b3ca441ef1369b3cf3e8333b | 283 | Pfam | PF07809 | RTP801 C-terminal region | 163 | 278 | 3.3E-44 | T | 22-09-2020 | IPR012918 | RTP801-like |
| UnnamedSample_HQ_transcript/5448|m.2348 | UnnamedSample_HQ_transcript/5448 | Coverage 0.975 too low. | aeaa07f5932e72c62d9d6e9939d7edb4 | 1460 | Pfam | PF12371 | Transmembrane protein 131-like | 74 | 158 | 5.6E-13 | T | 22-09-2020 | IPR022113 | Transmembrane protein 131-like domain |
| UnnamedSample_HQ_transcript/34727|m.10659 | UnnamedSample_HQ_transcript/34727 | Coverage 0.555 too low. | 59e36998a449a5a7c6079d0457419098 | 748 | Pfam | PF00595 | PDZ domain | 458 | 529 | 2.7E-9 | T | 22-09-2020 | IPR001478 | PDZ domain |
| UnnamedSample_HQ_transcript/34727|m.10659 | UnnamedSample_HQ_transcript/34727 | Coverage 0.555 too low. | 59e36998a449a5a7c6079d0457419098 | 748 | Pfam | PF00595 | PDZ domain | 640 | 721 | 9.1E-16 | T | 22-09-2020 | IPR001478 | PDZ domain |
| UnnamedSample_HQ_transcript/41664|m.12194 | UnnamedSample_HQ_transcript/41664 | Coverage 0.603 too low. | 59e36998a449a5a7c6079d0457419098 | 748 | Pfam | PF00595 | PDZ domain | 458 | 529 | 2.7E-9 | T | 22-09-2020 | IPR001478 | PDZ domain |
| UnnamedSample_HQ_transcript/41664|m.12194 | UnnamedSample_HQ_transcript/41664 | Coverage 0.603 too low. | 59e36998a449a5a7c6079d0457419098 | 748 | Pfam | PF00595 | PDZ domain | 640 | 721 | 9.1E-16 | T | 22-09-2020 | IPR001478 | PDZ domain |
| UnnamedSample_HQ_transcript/28690|m.9135 | UnnamedSample_HQ_transcript/28690 | Coverage 0.527 too low. | 59e36998a449a5a7c6079d0457419098 | 748 | Pfam | PF00595 | PDZ domain | 458 | 529 | 2.7E-9 | T | 22-09-2020 | IPR001478 | PDZ domain |
| UnnamedSample_HQ_transcript/28690|m.9135 | UnnamedSample_HQ_transcript/28690 | Coverage 0.527 too low. | 59e36998a449a5a7c6079d0457419098 | 748 | Pfam | PF00595 | PDZ domain | 640 | 721 | 9.1E-16 | T | 22-09-2020 | IPR001478 | PDZ domain |
| UnnamedSample_HQ_transcript/98701|m.22455 | UnnamedSample_HQ_transcript/98701 | Coverage 0.773 too low. | 15255a327b6f74b09ca0a0e103747b86 | 174 | Pfam | PF01553 | Acyltransferase | 10 | 103 | 5.0E-14 | T | 22-09-2020 | IPR002123 | Phospholipid/glycerol acyltransferase |
| UnnamedSample_HQ_transcript/20869|m.7109 | UnnamedSample_HQ_transcript/20869 | Coverage 0.153 too low. | 43bc95f2cff8f1d955eda1dc0a17a5fd | 485 | Pfam | PF00884 | Sulfatase | 1 | 269 | 1.4E-45 | T | 22-09-2020 | IPR000917 | Sulfatase, N-terminal |
| UnnamedSample_HQ_transcript/62902|m.16609 | UnnamedSample_HQ_transcript/62902 | Identity 0.852 too low. | 0eba86d34f746624fca9aecdc8bef8af | 366 | Pfam | PF07479 | NAD-dependent glycerol-3-phosphate dehydrogenase C-terminus | 195 | 340 | 1.8E-48 | T | 22-09-2020 | IPR006109 | Glycerol-3-phosphate dehydrogenase, NAD-dependent, C-terminal |
| UnnamedSample_HQ_transcript/62902|m.16609 | UnnamedSample_HQ_transcript/62902 | Identity 0.852 too low. | 0eba86d34f746624fca9aecdc8bef8af | 366 | Pfam | PF01210 | NAD-dependent glycerol-3-phosphate dehydrogenase N-terminus | 6 | 174 | 9.4E-51 | T | 22-09-2020 | IPR011128 | Glycerol-3-phosphate dehydrogenase, NAD-dependent, N-terminal |
| UnnamedSample_HQ_transcript/29966|m.9475 | UnnamedSample_HQ_transcript/29966 | Coverage 0.949 too low. | 6b2f819c8a721be3c824ef375bd2b63d | 347 | Pfam | PF02137 | Adenosine-deaminase (editase) domain | 14 | 331 | 4.6E-78 | T | 22-09-2020 | IPR002466 | Adenosine deaminase/editase |
| UnnamedSample_HQ_transcript/29994|m.9480 | UnnamedSample_HQ_transcript/29994 | Coverage 0.795 too low. | 329272623c0d520c8e299e1c9b8dd06f | 523 | Pfam | PF16179 | Rel homology dimerisation domain | 341 | 432 | 8.5E-25 | T | 22-09-2020 | IPR032397 | Rel homology dimerisation domain |
| UnnamedSample_HQ_transcript/29994|m.9480 | UnnamedSample_HQ_transcript/29994 | Coverage 0.795 too low. | 329272623c0d520c8e299e1c9b8dd06f | 523 | Pfam | PF00554 | Rel homology DNA-binding domain | 174 | 333 | 3.4E-28 | T | 22-09-2020 | IPR011539 | Rel homology domain (RHD), DNA-binding domain |
| UnnamedSample_HQ_transcript/1039|m.646 | UnnamedSample_HQ_transcript/1039 | Unmapped. | a7dee437e86d96199bb7d00a70e2ae2d | 2025 | Pfam | PF00910 | RNA helicase | 597 | 705 | 7.7E-18 | T | 22-09-2020 | IPR000605 | Helicase, superfamily 3, single-stranded DNA/RNA virus |
| UnnamedSample_HQ_transcript/1039|m.646 | UnnamedSample_HQ_transcript/1039 | Unmapped. | a7dee437e86d96199bb7d00a70e2ae2d | 2025 | Pfam | PF08762 | CRPV capsid protein like | 35 | 183 | 9.5E-9 | T | 22-09-2020 | IPR014872 | Dicistrovirus, capsid-polyprotein, C-terminal |
| UnnamedSample_HQ_transcript/1039|m.646 | UnnamedSample_HQ_transcript/1039 | Unmapped. | a7dee437e86d96199bb7d00a70e2ae2d | 2025 | Pfam | PF00680 | Viral RNA-dependent RNA polymerase | 1659 | 1984 | 3.3E-33 | T | 22-09-2020 | IPR001205 | RNA-directed RNA polymerase, C-terminal domain |
| UnnamedSample_HQ_transcript/1124|m.693 | UnnamedSample_HQ_transcript/1124 | Unmapped. | a7dee437e86d96199bb7d00a70e2ae2d | 2025 | Pfam | PF00910 | RNA helicase | 597 | 705 | 7.7E-18 | T | 22-09-2020 | IPR000605 | Helicase, superfamily 3, single-stranded DNA/RNA virus |
| UnnamedSample_HQ_transcript/1124|m.693 | UnnamedSample_HQ_transcript/1124 | Unmapped. | a7dee437e86d96199bb7d00a70e2ae2d | 2025 | Pfam | PF08762 | CRPV capsid protein like | 35 | 183 | 9.5E-9 | T | 22-09-2020 | IPR014872 | Dicistrovirus, capsid-polyprotein, C-terminal |
| UnnamedSample_HQ_transcript/1124|m.693 | UnnamedSample_HQ_transcript/1124 | Unmapped. | a7dee437e86d96199bb7d00a70e2ae2d | 2025 | Pfam | PF00680 | Viral RNA-dependent RNA polymerase | 1659 | 1984 | 3.3E-33 | T | 22-09-2020 | IPR001205 | RNA-directed RNA polymerase, C-terminal domain |
| UnnamedSample_HQ_transcript/76485|m.19117 | UnnamedSample_HQ_transcript/76485 | Coverage 0.911 too low. | 7fb55ba2fbe82d30fc2f6fad2544cc99 | 506 | Pfam | PF03097 | BRO1-like domain | 7 | 94 | 9.1E-20 | T | 22-09-2020 | IPR004328 | BRO1 domain |
| UnnamedSample_HQ_transcript/76485|m.19117 | UnnamedSample_HQ_transcript/76485 | Coverage 0.911 too low. | 7fb55ba2fbe82d30fc2f6fad2544cc99 | 506 | Pfam | PF13949 | ALIX V-shaped domain binding to HIV | 130 | 421 | 8.0E-82 | T | 22-09-2020 | IPR025304 | ALIX V-shaped domain |
| UnnamedSample_HQ_transcript/45157|m.12944 | UnnamedSample_HQ_transcript/45157 | Coverage 0.089 too low. | 1b6ac1fad90347576163ea60679d4706 | 641 | Pfam | PF01740 | STAS domain | 523 | 634 | 6.3E-22 | T | 22-09-2020 | IPR002645 | STAS domain |
| UnnamedSample_HQ_transcript/45157|m.12944 | UnnamedSample_HQ_transcript/45157 | Coverage 0.089 too low. | 1b6ac1fad90347576163ea60679d4706 | 641 | Pfam | PF00916 | Sulfate permease family | 92 | 472 | 2.2E-108 | T | 22-09-2020 | IPR011547 | SLC26A/SulP transporter domain |
| UnnamedSample_HQ_transcript/102763|m.22966 | UnnamedSample_HQ_transcript/102763 | Coverage 0.557 too low. | ffd595cd5b9be5d0996cc7b7e409abeb | 332 | Pfam | PF05485 | THAP domain | 23 | 109 | 5.9E-17 | T | 22-09-2020 | IPR006612 | THAP-type zinc finger |
| UnnamedSample_HQ_transcript/2008|m.1060 | UnnamedSample_HQ_transcript/2008 | Coverage 0.023 too low. | 997755bf6bbf530786904da7e9bcd08e | 1776 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 72 | 125 | 1.7E-7 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/2008|m.1060 | UnnamedSample_HQ_transcript/2008 | Coverage 0.023 too low. | 997755bf6bbf530786904da7e9bcd08e | 1776 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 310 | 365 | 3.9E-8 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/2008|m.1060 | UnnamedSample_HQ_transcript/2008 | Coverage 0.023 too low. | 997755bf6bbf530786904da7e9bcd08e | 1776 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 1468 | 1525 | 2.1E-7 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/2008|m.1060 | UnnamedSample_HQ_transcript/2008 | Coverage 0.023 too low. | 997755bf6bbf530786904da7e9bcd08e | 1776 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 1207 | 1264 | 8.7E-8 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/2008|m.1060 | UnnamedSample_HQ_transcript/2008 | Coverage 0.023 too low. | 997755bf6bbf530786904da7e9bcd08e | 1776 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 1140 | 1195 | 3.3E-9 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/2008|m.1060 | UnnamedSample_HQ_transcript/2008 | Coverage 0.023 too low. | 997755bf6bbf530786904da7e9bcd08e | 1776 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 562 | 616 | 1.1E-8 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/2008|m.1060 | UnnamedSample_HQ_transcript/2008 | Coverage 0.023 too low. | 997755bf6bbf530786904da7e9bcd08e | 1776 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 836 | 889 | 2.2E-7 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/2008|m.1060 | UnnamedSample_HQ_transcript/2008 | Coverage 0.023 too low. | 997755bf6bbf530786904da7e9bcd08e | 1776 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 1255 | 1313 | 1.9E-7 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/2008|m.1060 | UnnamedSample_HQ_transcript/2008 | Coverage 0.023 too low. | 997755bf6bbf530786904da7e9bcd08e | 1776 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 628 | 685 | 7.7E-9 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/2008|m.1060 | UnnamedSample_HQ_transcript/2008 | Coverage 0.023 too low. | 997755bf6bbf530786904da7e9bcd08e | 1776 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 928 | 980 | 6.6E-8 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/2008|m.1060 | UnnamedSample_HQ_transcript/2008 | Coverage 0.023 too low. | 997755bf6bbf530786904da7e9bcd08e | 1776 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 376 | 426 | 4.8E-7 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/2008|m.1060 | UnnamedSample_HQ_transcript/2008 | Coverage 0.023 too low. | 997755bf6bbf530786904da7e9bcd08e | 1776 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 949 | 1000 | 5.3E-7 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/2008|m.1060 | UnnamedSample_HQ_transcript/2008 | Coverage 0.023 too low. | 997755bf6bbf530786904da7e9bcd08e | 1776 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 262 | 313 | 1.7E-8 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/2008|m.1060 | UnnamedSample_HQ_transcript/2008 | Coverage 0.023 too low. | 997755bf6bbf530786904da7e9bcd08e | 1776 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 1077 | 1133 | 6.8E-9 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/2008|m.1060 | UnnamedSample_HQ_transcript/2008 | Coverage 0.023 too low. | 997755bf6bbf530786904da7e9bcd08e | 1776 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 1644 | 1753 | 1.2E-41 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/2008|m.1060 | UnnamedSample_HQ_transcript/2008 | Coverage 0.023 too low. | 997755bf6bbf530786904da7e9bcd08e | 1776 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 1534 | 1639 | 3.6E-38 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/68032|m.17581 | UnnamedSample_HQ_transcript/68032 | Coverage 0.961 too low. | 9685f614b7a4d81840387ddb492c365f | 225 | Pfam | PF00012 | Hsp70 protein | 3 | 87 | 4.0E-7 | T | 22-09-2020 | IPR013126 | Heat shock protein 70 family |
| UnnamedSample_HQ_transcript/4591|m.2033 | UnnamedSample_HQ_transcript/4591 | Identity 0.664 too low. | 7e6609394d1d73bb235c4990b824ce07 | 1490 | Pfam | PF12894 | Anaphase-promoting complex subunit 4 WD40 domain | 411 | 498 | 1.1E-5 | T | 22-09-2020 | IPR024977 | Anaphase-promoting complex subunit 4, WD40 domain |
| UnnamedSample_HQ_transcript/4591|m.2033 | UnnamedSample_HQ_transcript/4591 | Identity 0.664 too low. | 7e6609394d1d73bb235c4990b824ce07 | 1490 | Pfam | PF00400 | WD domain, G-beta repeat | 646 | 682 | 0.17 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/4591|m.2033 | UnnamedSample_HQ_transcript/4591 | Identity 0.664 too low. | 7e6609394d1d73bb235c4990b824ce07 | 1490 | Pfam | PF00400 | WD domain, G-beta repeat | 64 | 102 | 0.21 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/13017|m.4823 | UnnamedSample_HQ_transcript/13017 | Coverage 0.952 too low. | 138f94cb4de05b678b4e3b0e72ac2cc3 | 1031 | Pfam | PF02785 | Biotin carboxylase C-terminal domain | 227 | 335 | 2.4E-31 | T | 22-09-2020 | IPR005482 | Biotin carboxylase, C-terminal |
| UnnamedSample_HQ_transcript/13017|m.4823 | UnnamedSample_HQ_transcript/13017 | Coverage 0.952 too low. | 138f94cb4de05b678b4e3b0e72ac2cc3 | 1031 | Pfam | PF02786 | Carbamoyl-phosphate synthase L chain, ATP binding domain | 3 | 211 | 4.5E-78 | T | 22-09-2020 | IPR005479 | Carbamoyl-phosphate synthetase large subunit-like, ATP-binding domain |
| UnnamedSample_HQ_transcript/13017|m.4823 | UnnamedSample_HQ_transcript/13017 | Coverage 0.952 too low. | 138f94cb4de05b678b4e3b0e72ac2cc3 | 1031 | Pfam | PF00364 | Biotin-requiring enzyme | 963 | 1030 | 1.8E-18 | T | 22-09-2020 | IPR000089 | Biotin/lipoyl attachment |
| UnnamedSample_HQ_transcript/13017|m.4823 | UnnamedSample_HQ_transcript/13017 | Coverage 0.952 too low. | 138f94cb4de05b678b4e3b0e72ac2cc3 | 1031 | Pfam | PF00682 | HMGL-like | 418 | 688 | 2.0E-27 | T | 22-09-2020 | IPR000891 | Pyruvate carboxyltransferase |
| UnnamedSample_HQ_transcript/13017|m.4823 | UnnamedSample_HQ_transcript/13017 | Coverage 0.952 too low. | 138f94cb4de05b678b4e3b0e72ac2cc3 | 1031 | Pfam | PF02436 | Conserved carboxylase domain | 714 | 912 | 5.5E-70 | T | 22-09-2020 | IPR003379 | Carboxylase, conserved domain |
| UnnamedSample_HQ_transcript/10500|m.3988 | UnnamedSample_HQ_transcript/10500 | Coverage 0.915 too low. | 4232ee16dcc058051b5f7336440aeb6b | 331 | Pfam | PF00651 | BTB/POZ domain | 23 | 124 | 2.3E-26 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/9144|m.3558 | UnnamedSample_HQ_transcript/9144 | Coverage 0.981 too low. | 4232ee16dcc058051b5f7336440aeb6b | 331 | Pfam | PF00651 | BTB/POZ domain | 23 | 124 | 2.3E-26 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/44047|m.12726 | UnnamedSample_HQ_transcript/44047 | Coverage 0.978 too low. | 8fa4d9d4afef73bba35c192370cdee7a | 273 | Pfam | PF01412 | Putative GTPase activating protein for Arf | 14 | 120 | 1.0E-32 | T | 22-09-2020 | IPR001164 | Arf GTPase activating protein |
| UnnamedSample_HQ_transcript/1979|m.1047 | UnnamedSample_HQ_transcript/1979 | Coverage 0.950 too low. | 093a880571ee7485594ba6794f20f0e7 | 1587 | Pfam | PF00102 | Protein-tyrosine phosphatase | 1339 | 1571 | 4.6E-70 | T | 22-09-2020 | IPR000242 | PTP type protein phosphatase |
| UnnamedSample_HQ_transcript/2282|m.1165 | UnnamedSample_HQ_transcript/2282 | Coverage 0.961 too low. | 093a880571ee7485594ba6794f20f0e7 | 1587 | Pfam | PF00102 | Protein-tyrosine phosphatase | 1339 | 1571 | 4.6E-70 | T | 22-09-2020 | IPR000242 | PTP type protein phosphatase |
| UnnamedSample_HQ_transcript/5841|m.2477 | UnnamedSample_HQ_transcript/5841 | Identity 0.718 too low. | 1eca5c05f7e3d13c9ac2854ea6c4d5c5 | 1461 | Pfam | PF12057 | BCL2-associated athanogene 6 | 275 | 366 | 6.4E-20 | T | 22-09-2020 | IPR021925 | Large proline-rich protein BAG6 |
| UnnamedSample_HQ_transcript/5841|m.2477 | UnnamedSample_HQ_transcript/5841 | Identity 0.718 too low. | 1eca5c05f7e3d13c9ac2854ea6c4d5c5 | 1461 | Pfam | PF00240 | Ubiquitin family | 4 | 73 | 7.5E-17 | T | 22-09-2020 | IPR000626 | Ubiquitin-like domain |
| UnnamedSample_HQ_transcript/2529|m.1243 | UnnamedSample_HQ_transcript/2529 | Coverage 0.184 too low. | f7fb47b98383e85f61a387cedddbf50a | 238 | Pfam | PF00098 | Zinc knuckle | 123 | 139 | 4.9E-7 | T | 22-09-2020 | IPR001878 | Zinc finger, CCHC-type |
| UnnamedSample_HQ_transcript/2529|m.1243 | UnnamedSample_HQ_transcript/2529 | Coverage 0.184 too low. | f7fb47b98383e85f61a387cedddbf50a | 238 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 42 | 98 | 9.6E-9 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/16053|m.5728 | UnnamedSample_HQ_transcript/16053 | Coverage 0.047 too low. | b336eb00b4d5cce386f0dfc5252f8d60 | 370 | Pfam | PF03145 | Seven in absentia protein family | 260 | 360 | 3.2E-9 | T | 22-09-2020 | IPR018121 | Seven-in-absentia protein, TRAF-like domain |
| UnnamedSample_HQ_transcript/60857|m.16229 | UnnamedSample_HQ_transcript/60857 | Identity 0.950 too low. | 20f5dd96b9e1b44adf330ba31ff4191b | 317 | Pfam | PF00209 | Sodium:neurotransmitter symporter family | 275 | 313 | 6.4E-16 | T | 22-09-2020 | IPR000175 | Sodium:neurotransmitter symporter |
| UnnamedSample_HQ_transcript/17997|m.6300 | UnnamedSample_HQ_transcript/17997 | Coverage 0.128 too low. | cdde3b6dbdce102afc0bd81b9a4d15a8 | 1130 | Pfam | PF02181 | Formin Homology 2 Domain | 373 | 756 | 5.4E-86 | T | 22-09-2020 | IPR015425 | Formin, FH2 domain |
| UnnamedSample_HQ_transcript/17997|m.6300 | UnnamedSample_HQ_transcript/17997 | Coverage 0.128 too low. | cdde3b6dbdce102afc0bd81b9a4d15a8 | 1130 | Pfam | PF06367 | Diaphanous FH3 Domain | 74 | 255 | 2.7E-28 | T | 22-09-2020 | IPR010472 | Formin, FH3 domain |
| UnnamedSample_HQ_transcript/39056|m.11644 | UnnamedSample_HQ_transcript/39056 | Coverage 0.896 too low. | b11fceb6ebd9e5b426630c68f39904b0 | 309 | Pfam | PF02826 | D-isomer specific 2-hydroxyacid dehydrogenase, NAD binding domain | 1 | 185 | 1.2E-55 | T | 22-09-2020 | IPR006140 | D-isomer specific 2-hydroxyacid dehydrogenase, NAD-binding domain |
| UnnamedSample_HQ_transcript/61647|m.16378 | UnnamedSample_HQ_transcript/61647 | Coverage 0.675 too low. | 42c72c254036067b8ce4fb4a032d862f | 448 | Pfam | PF00096 | Zinc finger, C2H2 type | 398 | 418 | 0.0013 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/61647|m.16378 | UnnamedSample_HQ_transcript/61647 | Coverage 0.675 too low. | 42c72c254036067b8ce4fb4a032d862f | 448 | Pfam | PF00096 | Zinc finger, C2H2 type | 365 | 387 | 0.0062 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/61647|m.16378 | UnnamedSample_HQ_transcript/61647 | Coverage 0.675 too low. | 42c72c254036067b8ce4fb4a032d862f | 448 | Pfam | PF16622 | zinc-finger C2H2-type | 423 | 445 | 4.7E-6 | T | 22-09-2020 | IPR041697 | Zinc-finger C2H2-type 11 |
| UnnamedSample_HQ_transcript/61647|m.16378 | UnnamedSample_HQ_transcript/61647 | Coverage 0.675 too low. | 42c72c254036067b8ce4fb4a032d862f | 448 | Pfam | PF00651 | BTB/POZ domain | 23 | 116 | 1.5E-24 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/75188|m.18879 | UnnamedSample_HQ_transcript/75188 | Identity 0.920 too low. | 1475463e180ed3c3af80b26c4be8657b | 415 | Pfam | PF09298 | Fumarylacetoacetase N-terminal | 18 | 116 | 9.3E-30 | T | 22-09-2020 | IPR015377 | Fumarylacetoacetase, N-terminal |
| UnnamedSample_HQ_transcript/75188|m.18879 | UnnamedSample_HQ_transcript/75188 | Identity 0.920 too low. | 1475463e180ed3c3af80b26c4be8657b | 415 | Pfam | PF01557 | Fumarylacetoacetate (FAA) hydrolase family | 130 | 407 | 1.5E-48 | T | 22-09-2020 | IPR011234 | Fumarylacetoacetase-like, C-terminal |
| UnnamedSample_HQ_transcript/82069|m.20040 | UnnamedSample_HQ_transcript/82069 | Identity 0.918 too low. | 1475463e180ed3c3af80b26c4be8657b | 415 | Pfam | PF09298 | Fumarylacetoacetase N-terminal | 18 | 116 | 9.3E-30 | T | 22-09-2020 | IPR015377 | Fumarylacetoacetase, N-terminal |
| UnnamedSample_HQ_transcript/82069|m.20040 | UnnamedSample_HQ_transcript/82069 | Identity 0.918 too low. | 1475463e180ed3c3af80b26c4be8657b | 415 | Pfam | PF01557 | Fumarylacetoacetate (FAA) hydrolase family | 130 | 407 | 1.5E-48 | T | 22-09-2020 | IPR011234 | Fumarylacetoacetase-like, C-terminal |
| UnnamedSample_HQ_transcript/17538|m.6171 | UnnamedSample_HQ_transcript/17538 | Coverage 0.844 too low. | 33cced563efdf610cd0b6e147788d974 | 782 | Pfam | PF02801 | Beta-ketoacyl synthase, C-terminal domain | 268 | 384 | 2.2E-40 | T | 22-09-2020 | IPR014031 | Beta-ketoacyl synthase, C-terminal |
| UnnamedSample_HQ_transcript/17538|m.6171 | UnnamedSample_HQ_transcript/17538 | Coverage 0.844 too low. | 33cced563efdf610cd0b6e147788d974 | 782 | Pfam | PF00698 | Acyl transferase domain | 516 | 741 | 1.8E-67 | T | 22-09-2020 | IPR014043 | Acyl transferase |
| UnnamedSample_HQ_transcript/17538|m.6171 | UnnamedSample_HQ_transcript/17538 | Coverage 0.844 too low. | 33cced563efdf610cd0b6e147788d974 | 782 | Pfam | PF00109 | Beta-ketoacyl synthase, N-terminal domain | 27 | 264 | 2.3E-69 | T | 22-09-2020 | IPR014030 | Beta-ketoacyl synthase, N-terminal |
| UnnamedSample_HQ_transcript/17538|m.6171 | UnnamedSample_HQ_transcript/17538 | Coverage 0.844 too low. | 33cced563efdf610cd0b6e147788d974 | 782 | Pfam | PF16197 | Ketoacyl-synthetase C-terminal extension | 387 | 496 | 5.1E-37 | T | 22-09-2020 | IPR032821 | Polyketide synthase, C-terminal extension |
| UnnamedSample_HQ_transcript/71200|m.18148 | UnnamedSample_HQ_transcript/71200 | Identity 0.912 too low. | 101669483575576ad04c2e3985440742 | 362 | Pfam | PF01299 | Lysosome-associated membrane glycoprotein (Lamp) | 146 | 295 | 7.2E-16 | T | 22-09-2020 | IPR002000 | Lysosome-associated membrane glycoprotein |
| UnnamedSample_HQ_transcript/2737|m.1332 | UnnamedSample_HQ_transcript/2737 | Unmapped. | 1c2a892f658f246f9d9f6d12b034ce9d | 1670 | Pfam | PF00680 | Viral RNA-dependent RNA polymerase | 1304 | 1629 | 2.4E-33 | T | 22-09-2020 | IPR001205 | RNA-directed RNA polymerase, C-terminal domain |
| UnnamedSample_HQ_transcript/2737|m.1332 | UnnamedSample_HQ_transcript/2737 | Unmapped. | 1c2a892f658f246f9d9f6d12b034ce9d | 1670 | Pfam | PF00910 | RNA helicase | 242 | 350 | 6.1E-18 | T | 22-09-2020 | IPR000605 | Helicase, superfamily 3, single-stranded DNA/RNA virus |
| UnnamedSample_HQ_transcript/39999|m.11846 | UnnamedSample_HQ_transcript/39999 | Coverage 0.164 too low. | 96d30d6c357429261fe26b1adfd758dd | 785 | Pfam | PF00757 | Furin-like cysteine rich region | 249 | 398 | 1.3E-25 | T | 22-09-2020 | IPR006211 | Furin-like cysteine-rich domain |
| UnnamedSample_HQ_transcript/39999|m.11846 | UnnamedSample_HQ_transcript/39999 | Coverage 0.164 too low. | 96d30d6c357429261fe26b1adfd758dd | 785 | Pfam | PF01030 | Receptor L domain | 414 | 527 | 2.0E-25 | T | 22-09-2020 | IPR000494 | Receptor L-domain |
| UnnamedSample_HQ_transcript/39999|m.11846 | UnnamedSample_HQ_transcript/39999 | Coverage 0.164 too low. | 96d30d6c357429261fe26b1adfd758dd | 785 | Pfam | PF01030 | Receptor L domain | 108 | 219 | 1.0E-26 | T | 22-09-2020 | IPR000494 | Receptor L-domain |
| UnnamedSample_HQ_transcript/109324|m.23754 | UnnamedSample_HQ_transcript/109324 | Coverage 0.929 too low. | 90fe8c302969caaf26eeeb565cd76649 | 161 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 29 | 138 | 1.5E-43 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/104728|m.23201 | UnnamedSample_HQ_transcript/104728 | Coverage 0.252 too low. | cff2ac2da83a320c82c91e39e76940bf | 273 | Pfam | PF07978 | NIPSNAP | 174 | 271 | 6.6E-34 | T | 22-09-2020 | IPR012577 | NIPSNAP |
| UnnamedSample_HQ_transcript/104728|m.23201 | UnnamedSample_HQ_transcript/104728 | Coverage 0.252 too low. | cff2ac2da83a320c82c91e39e76940bf | 273 | Pfam | PF07978 | NIPSNAP | 64 | 156 | 4.6E-6 | T | 22-09-2020 | IPR012577 | NIPSNAP |
| UnnamedSample_HQ_transcript/87385|m.20853 | UnnamedSample_HQ_transcript/87385 | Coverage 0.438 too low. | cff2ac2da83a320c82c91e39e76940bf | 273 | Pfam | PF07978 | NIPSNAP | 174 | 271 | 6.6E-34 | T | 22-09-2020 | IPR012577 | NIPSNAP |
| UnnamedSample_HQ_transcript/87385|m.20853 | UnnamedSample_HQ_transcript/87385 | Coverage 0.438 too low. | cff2ac2da83a320c82c91e39e76940bf | 273 | Pfam | PF07978 | NIPSNAP | 64 | 156 | 4.6E-6 | T | 22-09-2020 | IPR012577 | NIPSNAP |
| UnnamedSample_HQ_transcript/84433|m.20404 | UnnamedSample_HQ_transcript/84433 | Coverage 0.455 too low. | cff2ac2da83a320c82c91e39e76940bf | 273 | Pfam | PF07978 | NIPSNAP | 174 | 271 | 6.6E-34 | T | 22-09-2020 | IPR012577 | NIPSNAP |
| UnnamedSample_HQ_transcript/84433|m.20404 | UnnamedSample_HQ_transcript/84433 | Coverage 0.455 too low. | cff2ac2da83a320c82c91e39e76940bf | 273 | Pfam | PF07978 | NIPSNAP | 64 | 156 | 4.6E-6 | T | 22-09-2020 | IPR012577 | NIPSNAP |
| UnnamedSample_HQ_transcript/87662|m.20886 | UnnamedSample_HQ_transcript/87662 | Coverage 0.313 too low. | f42baebc328c4e210eb076a60ec9dc6c | 416 | Pfam | PF00155 | Aminotransferase class I and II | 156 | 403 | 7.6E-27 | T | 22-09-2020 | IPR004839 | Aminotransferase, class I/classII |
| UnnamedSample_HQ_transcript/25914|m.8454 | UnnamedSample_HQ_transcript/25914 | Unmapped. | 9622b9281a01d03593713bce84842eb9 | 804 | Pfam | PF17222 | Viral cysteine endopeptidase C107 | 195 | 450 | 2.1E-11 | T | 22-09-2020 | IPR033777 | Viral cysteine endopeptidase C107 |
| UnnamedSample_HQ_transcript/102794|m.22969 | UnnamedSample_HQ_transcript/102794 | Identity 0.764 too low. | 8617c3659eeda4e9199a5f0607abc598 | 214 | Pfam | PF00567 | Tudor domain | 73 | 154 | 4.4E-12 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/35703|m.10860 | UnnamedSample_HQ_transcript/35703 | Coverage 0.988 too low. | f0817cac67ad47a0b489471556b98379 | 487 | Pfam | PF07714 | Protein tyrosine and serine/threonine kinase | 191 | 462 | 2.2E-78 | T | 22-09-2020 | IPR001245 | Serine-threonine/tyrosine-protein kinase, catalytic domain |
| UnnamedSample_HQ_transcript/89066|m.21094 | UnnamedSample_HQ_transcript/89066 | Coverage 0.954 too low. | 5e75e7528951f00b04dc2633bb771a27 | 357 | Pfam | PF00128 | Alpha amylase, catalytic domain | 1 | 188 | 2.1E-14 | T | 22-09-2020 | IPR006047 | Glycosyl hydrolase, family 13, catalytic domain |
| UnnamedSample_HQ_transcript/93364|m.21718 | UnnamedSample_HQ_transcript/93364 | Identity 0.731 too low. | 036e204963625396168dae9d34c9f0da | 378 | Pfam | PF00501 | AMP-binding enzyme | 107 | 374 | 1.2E-47 | T | 22-09-2020 | IPR000873 | AMP-dependent synthetase/ligase |
| UnnamedSample_HQ_transcript/1296|m.767 | UnnamedSample_HQ_transcript/1296 | Coverage 0.246 too low. | 5e0021a45f24b52c0d68b338ae8003eb | 1546 | Pfam | PF01839 | FG-GAP repeat | 409 | 452 | 2.0E-6 | T | 22-09-2020 | IPR013517 | FG-GAP repeat |
| UnnamedSample_HQ_transcript/1296|m.767 | UnnamedSample_HQ_transcript/1296 | Coverage 0.246 too low. | 5e0021a45f24b52c0d68b338ae8003eb | 1546 | Pfam | PF01839 | FG-GAP repeat | 331 | 371 | 3.1E-10 | T | 22-09-2020 | IPR013517 | FG-GAP repeat |
| UnnamedSample_HQ_transcript/1296|m.767 | UnnamedSample_HQ_transcript/1296 | Coverage 0.246 too low. | 5e0021a45f24b52c0d68b338ae8003eb | 1546 | Pfam | PF08441 | Integrin alpha | 518 | 959 | 1.4E-74 | T | 22-09-2020 | IPR013649 | Integrin alpha-2 |
A
B
C
D
E
F
G
H
I
J
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
| 1. Protein accession (e.g. P51587) | |||||||||
| 2. Sequence MD5 digest (e.g. 14086411a2cdf1c4cba63020e1622579) | |||||||||
| 3. Sequence length (e.g. 3418) | |||||||||
| 4. Analysis (e.g. Pfam / PRINTS / Gene3D) | |||||||||
| 5. Signature accession (e.g. PF09103 / G3DSA:2.40.50.140) | |||||||||
| 6. Signature description (e.g. BRCA2 repeat profile) | |||||||||
| 7. Start location | |||||||||
| 8. Stop location | |||||||||
| 9. Score - is the e-value (or score) of the match reported by member database method (e.g. 3.1E-52) | |||||||||
| 10. Status - is the status of the match (T: true) | |||||||||
| 11. Date - is the date of the run | |||||||||
| 12. (InterPro annotations - accession (e.g. IPR002093) - optional column; only displayed if -iprlookup option is switched on) | |||||||||
| 13. (InterPro annotations - description (e.g. BRCA2 repeat) - optional column; only displayed if -iprlookup option is switched on) | |||||||||
